BG Medicine said this week that the 2013 American College of Cardiology Foundation and the American Heart Association Guideline for the Management of Heart Failure has for the first time recognized the role of galectin-3 testing.

This recognition could help drive clinical adoption of the company's BGM-Galectin-3 heart failure diagnostic.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.